BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 714103)

  • 1. Congenital deficiency of C2 and factor B.
    Raum D; Glass D; Agnello V; Schur P; Alper CA
    N Engl J Med; 1978 Dec; 299(23):1313. PubMed ID: 714103
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway.
    Newman SL; Vogler LB; Feigin RD; Johnston RB
    N Engl J Med; 1978 Aug; 299(6):290-2. PubMed ID: 661928
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective deficiencies in complement component : a family with hereditary C2 deficiency.
    Dantant M; Rivat C; Gilbert D; Fontaine M; Cavelier B; Godin M; Fillastre JP
    Biomedicine; 1978; 28(3):185-90. PubMed ID: 698338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The complement system. Normal values and congenital deficiencies in the adult Mexican population].
    Becerra Posada C; Reyes PA
    Arch Inst Cardiol Mex; 1985; 55(3):243-6. PubMed ID: 2932077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of C4 isotypes and factor B in type I C2 deficiency suggest haplotype-dependent quantitative expression of MHC class III complement genes.
    Truedsson L; Gullstrand B; Jönsson T; Klint C
    Exp Clin Immunogenet; 1995; 12(2):66-73. PubMed ID: 7576717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymorphism of the C2 and factor B gene.
    Cross SJ; Thomson W
    Exp Clin Immunogenet; 1990; 7(1):53-63. PubMed ID: 1971758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of histamine on the gene expression and biosynthesis of complement components C2, factor B and C3 in mouse peritoneal macrophages.
    Falus A; Meretey K
    Immunology; 1987 Apr; 60(4):547-51. PubMed ID: 3646991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disseminated lupus erythematosus and hereditary C2 deficiency].
    Dantant M; Godin M; Rivat C; Dubois D; Gilbert D; Fontaine M; Cavelier B; Fillastre JP
    J Urol Nephrol (Paris); 1978; 84(4-5):347-9. PubMed ID: 308105
    [No Abstract]   [Full Text] [Related]  

  • 9. C2 and factor B: structure and genetics.
    Bentley DR; Campbell RD
    Biochem Soc Symp; 1986; 51():7-18. PubMed ID: 3101701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Properdin factor B: polymorphism, synthesis site and first case of genetic deficiency].
    Hauptmann G; Tongio MM; Klein J; Mayer S; Cinqualbre J; Jeanblanc B; Kieny R; Mauff G; Federmann G
    Nouv Presse Med; 1980 Jan; 9(1):45. PubMed ID: 6898304
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages.
    Lappin D; Hamilton AD; Morrison L; Aref M; Whaley K
    J Clin Lab Immunol; 1986 Jul; 20(3):101-5. PubMed ID: 3638367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement.
    Raum D; Glass D; Carpenter CB; Alper CA; Schur PH
    J Clin Invest; 1976 Nov; 58(5):1240-8. PubMed ID: 993342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of factor B in residual immune complex red cell binding activity observed in serum from a C2-deficient systemic lupus erythematosus patient may delay the appearance of clinical symptoms.
    Traustadóttir KH; Rafnar BO; Steinsson K; Valdimarsson H; Erlendsson K
    Arthritis Rheum; 1998 Mar; 41(3):427-34. PubMed ID: 9506570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.
    Nydegger UE; Fearon DT; Austen KF
    J Immunol; 1978 Apr; 120(4):1404-8. PubMed ID: 565382
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum-treated antigen-antibody complexes inhibit the production of C2 and factor B by mononuclear phagocytes.
    Whaley K; Lappin D; Hamilton AO
    Immunology; 1983 Feb; 48(2):255-63. PubMed ID: 6549747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1s-induced vascular permeability in C2-deficient guinea pigs.
    Strang CJ; Auerbach HS; Rosen FS
    J Immunol; 1986 Jul; 137(2):631-5. PubMed ID: 3487577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B, C2 and C4 complement factors, the HLA system and diseases. Genetic relation].
    Doutre MS
    Pathol Biol (Paris); 1983 Sep; 31(7):622-30. PubMed ID: 6355995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency.
    Boeckler P; Milea M; Meyer A; Uring-Lambert B; Heid E; Hauptmann G; Cribier B; Lipsker D
    Br J Dermatol; 2005 Feb; 152(2):265-70. PubMed ID: 15727637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are major histocompatibility system class III products independent markers for susceptibility to rheumatoid arthritis?
    Dyer PA; Thomson W; Sanders PA; Grennan DM
    Dis Markers; 1986 Jun; 4(1-2):151-5. PubMed ID: 3330696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.